• at distribution kun kan finde sted efter forudgående verifikation af, at patienten faktisk har fået en meningokokvaccination med skriftlig bekræftelse heraf, • at al sundhedspersonale inden distribution er blevet oplyst om følgende sikkerhedsmæssige hovedproblemer:
• drug distribution will only be possible after checking that the patient has effectively received a meningococcal vaccination with a written confirmation • prior to distribution, all health care professionals are provided with information on the following key safety concerns: